Filana Therapeutics Inc.

FLNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.62

-$0.04 (-5.78%)

At close: Oct 30, 2026, 4:00 PM ET

$0.62

$0.00 (+0.42%)

Pre-market: Nov 2, 2026, 9:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024
Net Income	-8.6M	-12.54M	-10.81M	-23.4M	-27.6M	-27.94M
Depreciation & Amortization	300K	367K	131K	220K	260K	259K
Stock-Based Compensation	n/a	n/a	4.4M	n/a	5.74M	5.61M
Other Working Capital	331K	1.18M	-2.91M	6.08M	4.92M	4.09M
Other Non-Cash Items	4.02M	5.37M	n/a	5.23M	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	433K	-2.95M	53K	6.62M	-39.67M	3.78M
Operating Cash Flow	-3.86M	-9.75M	-6.22M	-11.34M	-61.27M	-18.3M
Capital Expenditures	-21K	-501K	-80K	n/a	-57K	-17K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-21K	-501K	-80K	n/a	-57K	-17K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-16K	n/a	n/a	n/a	918K	n/a
Financial Cash Flow	-16K	-329K	n/a	90K	918K	n/a
Net Cash Flow	-3.89M	-10.58M	-6.3M	-11.25M	-60.4M	-18.31M
Free Cash Flow	-3.88M	-10.25M	-6.3M	-11.34M	-61.32M	-18.31M
Adj. Free Cash Flow	-3.88M	-10.25M	-10.7M	-11.34M	-67.07M	-23.92M
Maintenance CapEx	-21K	-367K	-80K	n/a	-57K	-17K
Growth CapEx	n/a	-134K	n/a	n/a	n/a	n/a
Owner Earnings	-3.88M	-10.12M	-6.3M	-11.34M	-61.32M	-18.31M